Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10031985HBVENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS30002251HIVENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS30036965HIVENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS20051793HPVENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS20068074HPVENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS44041650HTLV-1ENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TVIS44035189HTLV-1ENSG00000100596.8protein_codingSPTLC2NoNo9517O15270
TCGA Plot Options
Drug Information
GeneSPTLC2
DrugBank IDDB00114
Drug NamePyridoxal phosphate
Target IDBE0000660
UniProt IDO15270
Regulation Typecofactor
PubMed IDs12782147; 11726713; 11781309; 11279212; 11171191
CitationsHanada K: Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16-30.@@Tamura K, Mitsuhashi N, Hara-Nishimura I, Imai H: Characterization of an Arabidopsis cDNA encoding a subunit of serine palmitoyltransferase, the initial enzyme in sphingolipid biosynthesis. Plant Cell Physiol. 2001 Nov;42(11):1274-81.@@Gable K, Han G, Monaghan E, Bacikova D, Natarajan M, Williams R, Dunn TM: Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase. J Biol Chem. 2002 Mar 22;277(12):10194-200. Epub 2002 Jan 7.@@Ikushiro H, Hayashi H, Kagamiyama H: A water-soluble homodimeric serine palmitoyltransferase from Sphingomonas paucimobilis EY2395T strain. Purification, characterization, cloning, and overproduction. J Biol Chem. 2001 May 25;276(21):18249-56. Epub 2001 Mar 12.@@Tamura K, Nishiura H, Mori J, Imai H: Cloning and characterization of a cDNA encoding serine palmitoyltransferase in Arabidopsis thaliana. Biochem Soc Trans. 2000 Dec;28(6):745-7.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPyridoxals and derivatives
SMILESCC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
PathwaysHistidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling
PharmGKBPA164749650
ChEMBLCHEMBL82202